Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Soligenix (SNGX)
NASDAQ:SNGX
Soligenix (SNGX) Stock Price & Analysis
527 Followers
SNGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.65 - $15.00
Previous Close$0.73
Volume212.29K
Average Volume (3M)872.10K
Market Cap
$5.88M
Enterprise Value$4.84M
Total Cash (Recent Filing)$10.27M
Total Debt (Recent Filing)$9.22M
Price to Earnings (P/E)-0.2
Beta0.60
Next Earnings
Aug 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.65
Shares Outstanding8,115,854
10 Day Avg. Volume287,176
30 Day Avg. Volume872,103
Standard Deviation0.28
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.60
Price to Sales (P/S)22.88
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.13
Enterprise Value/Gross Profit12.16
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Soligenix News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNGX FAQ
What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $0.65 and its highest was $15.00 in the past 12 months.
What is Soligenix’s market cap?
Currently, no data Available
When is Soligenix’s upcoming earnings report date?
Soligenix’s upcoming earnings report date is Aug 10, 2023 which is in 75 days.
How were Soligenix’s earnings last quarter?
Currently, no data Available
Is Soligenix overvalued?
According to Wall Street analysts Soligenix’s price is currently Overvalued.
Does Soligenix pay dividends?
Soligenix does not currently pay dividends.
What is Soligenix’s EPS estimate?
Soligenix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Soligenix have?
Soligenix has 8,115,854 shares outstanding.
What happened to Soligenix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Soligenix?
Currently, no hedge funds are holding shares in SNGX
---
Soligenix Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.31%
12-Months-Change
Fundamentals
Return on Equity
-656.49%
Trailing 12-Months
Asset Growth
-53.11%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Soligenix
Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.
---
Top 5 ETFs holding SNGX
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold SNGX. The ETFs are listed according to market value of SNGX within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
CASI Pharmaceuticals
―
Spruce Biosciences
―
Codiak BioSciences
―
Inhibitor Therapeutics
―
Marker Therapeutics
―
---